Packaging of one-component vaccine against COVID-19 «Sputnik Light»ROME, February 4, Alexander Logunov. The first tourists, Those who came to San Marino for a booster dose of the coronavirus vaccine were vaccinated with the Russian drug Sputnik Light, a representative of the Institute of Social Security of the Republic (ISS) told RIA Novosti. According to him, the San Marino authorities decided to resume «vaccine tourism» after how more than 1,200 people applied for paid vaccination with Sputnik V last summer.New entry rules: where is it better for Russians vaccinated with Sputnik Lite to fly «Today, the first ten people received a booster. They arrived from Germany, Estonia and Latvia. Last summer they also visited San Marino,» the agency's interlocutor said. tourists are of Russian origin, others are Italians married to Russian women. The cost of obtaining the Russian vaccine remained the same and amounted to 50 euros. Another condition is primary vaccination with Sputnik V. In total, more than 30 foreign citizens applied for a Russian booster in San Marino, an ISS representative said. production of «Sputnik Light» in Hungary In addition, on Friday there was another reception of citizens of San Marino who wished to receive a third dose of «Sputnik», he added. In total, about 130 people applied for it, 832 people have been vaccinated with Sputnik Light since the end of December. The next rounds of revaccination with the Russian drug are planned until the end of February, while three more are scheduled. It is possible, the interlocutor added, that there will be more people who want to resort to the vaccine from the Russian Federation again, given that foreign citizens in Italy who have previously been vaccinated against coronavirus, even with drugs that are still not recognized in the Apennines, will now be able to access basic services after the test. on COVID-19. In total, more than 17 thousand residents of San Marino received the third dose of the coronavirus vaccine — that is, 62% of the population aged 12 years and older, the ISS reported. Two doses are available in 80% of the population over 5 years of age.